Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1994-12-07
1998-09-08
Caputa, Anthony C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424 934, 4242351, 4242581, 424 932, A61K 39112
Patent
active
058041940
ABSTRACT:
Attenuated microorganism for use in immunoprophylaxis in which the attenuation is brought about by the presence of a mutation in the DNA sequence of the microorganism which encodes, or which regulates the expression of DNA encoding a protein that is produced in response to environmental stress, the microorganism optionally being capable of expressing DNA encoding a heterologous antigen.
REFERENCES:
patent: 5114844 (1992-05-01), Cohen
Sanderson et al. "Escherichia coli and Salmonella Typni-Murium" vol. 2, published in 1987 by American Society of Microbiology (see pp. 877-918).
Lazar et al. Mol. Cell Biology 8(3):1247-1252, 1988.
Burgess et al. J. Cell Biology 111:2129-37, 1990.
"E. coli and Salmonella typhimurium, Cellular and Molecular Immunology" F.C. Neidherdt et al (Ed) published in 1987; see pp. 378-380.
Hone et al, "Construction of genetically defined double aro mutants of Salmonella typhi", Vaccine 9:810-816 (1991).
Tracket et al, "Comparison of the Safety and Immunogenicity of .increment.aroC .increment.aroD and .increment.acyo .increment.crp Salmonella typhi Strains in Adult Volunteers", Infection and Immunity 60:536-541 (1992).
Tracket at al, "Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain", Vaccine 10:443-446 (1992).
Collins, "Vaccines and Cell-Mediated Immunity", Bacteriological Reviews 38:371-402 (1974).
O'Callaghan et al, "Characterization of Aromatic-and Purine-Dependent Salmonella typhimurium: Attenuation, Persistence, and Ability to Induce Protective Immunity in BALB/c Mice", Infection and Immunity 56:419-423 (1988).
Jones et al, "Oral vaccination of calves against experimental salmonellosis using a double aro mutant of Salmonella typhimurium", Vaccine 9:29-34 (1991).
Miller et al, "Bacteriophage P22 as a vehicle for transducing cosmid gene banks between smooth strains of Salmonella typhimurium: Use in identifying a role for iroD in attenuating virulent Salmonella strains", Mol. Gen. Genet. 215:312-316 (1989).
Dougan et al, "Construction and Characterization of Vaccine Strains of Salmonella Harboring Mutations in Two Different aro Genes", The Journal of Infectious Diseases 158(6):1329-1335 (1988).
I. Miller et al, Infection and Immunity 57, No. 9, 1989 2758-2763.
B. Lipinska et al, J. Bacteriology 171, No. 3, 1989, 1574-1584.
B. Bukau, J. Bacteriology, 171, No. 5, 1989, 2337-2346.
Kusukawa et al, Genes and Development 2, 1988, 874-882.
N. Kusukawa et al, The EMBO Journal, 8, No. 11, 1989, 3517-3521.
Groisman et al, Proc. Natl. Acad. Sci., 86, 1989, 7077-7081.
J.W. Foster et al, J. Bacteriology, 172, No. 2, 1990, 771-778.
S.N. Chatfield et al, Vaccine 7, No. 6, 1989, 495-498.
K. Johnson et al, Biological Abstracts, 91, Abstract 119974 & Mol. Microbiol 5 (2), 1991, 401-408.
Bacon et al, BR.J.Exp. Path 31, 714-724 (1950).
Roy Curtiss III et al, Vaccine 6, 155-160 (1988).
Dorman et al, Infec. Immun. 57, 2136-2140 (1989).
Fields et al, Science 243, 1059-1062 (1989).
Niedhardt et al, Cell. and Mol. Biol. 1334-1345 (1987).
Lipinska et al, Nuc. Acids. Res 21, 10053-67 (1988).
Lipinska et al, J. Bacteriol. 171, 1574-1584 (1989).
Strauch et al, Proc. Natl. Acad. Sci. 85, 1576-1580 (1988).
Maniol et al, Proc. Natl. Acad. Sci. 82, 8129-8133 (1985).
Ronson et al, Cell, 49, 579-581 (1987).
Buck et al, Nature, 320, 374-378 (1986).
Hirschman et al, Proc. Natl. Acad. Sci. 82, 7275 (1985).
Nixon et al, Proc. Natl. Acad. Sci. 83, 7850-7854 (1986).
Reitzer et al, Cell. 45, 785 (1986).
Makino et al, J. Mol. Biol. 192, 549-556 (1986).
Albin et al, J. Biol. Chem. 261, 4698 (1986).
Drury et al, J. Biol. Chem. 260, 4236-4272 (1985).
Ronson et al, J. Bacteriol, 169, 2424 (1987).
Winans et al, Proc. Natl. Acad. Sci. 83, 8278 (1986).
Arico et al, Proc. Natl. Acad. Sci. 86, 6671-6675 (1989).
Clements et al, Infec. and Immun. 46, 2, 564-569 (1984).
Formal et al, Infec. and Immun. 34, 746-750.
Chatfield et al, Microb. Pathog. 12:145-121.
"E. coli and Salmonella Typhimurium", Cellular and Molecular Biology, Neidhardt et al (Ed) published in 1987, see pp. 378-380.
Charles Ian George
Chatfield Steven Neville
Dougan Gordan
Hormaeche Carlos Estenio
Johnson Kevin Stuart
Caputa Anthony C.
Glaxo Wellcome Inc.
LandOfFree
Vaccines containing a salmonella bacteria attenuated by mutation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccines containing a salmonella bacteria attenuated by mutation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccines containing a salmonella bacteria attenuated by mutation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1279636